Hotspots in clinical management of severe liver diseases
10.3969/j.issn.1001-5256.2017.09.001
- VernacularTitle:关注重症肝病临床管理的热点问题
- Author:
Jiayu LYU
1
;
Tao HAN
Author Information
1. 天津市第三中心医院肝内科
- Keywords:
liver failure;
liver cirrhosis;
liver,artificial;
liver transplantation;
diagnosis;
treatment;
editorial
- From:
Journal of Clinical Hepatology
2017;33(9):1617-1620
- CountryChina
- Language:Chinese
-
Abstract:
Severe liver diseases such as liver failure and acute decompensated cirrhosis have critical conditions and high mortality rates,and the prognosis of such patients is closely associated with early warning,timely dynamic assessment,and comprehensive and effective therapy.The patients require a series of effective clinical management measures for elimination of causative factors,organ support,and prevention and treatment of complications.Medical treatment-artificial liver-liver transplantation is an important modality for severe liver diseases.Granulocyte colony-stimulating factor,stem cell therapy,and bioartificial liver have a promising future,while there are still controversies over non-selective β-blocker.This article reviews the hotspots in the clinical management of severe liver diseases.
